帝奧微(688381.SH):上半年淨利潤2676.58萬元,同比下降7.61%
格隆匯8月16日丨帝奧微(688381.SH)公佈2024年半年度報吿,報吿期實現營業收入2.66億元,同比增長47.28%;歸屬於上市公司股東的淨利潤2676.58萬元,同比下降7.61%;歸屬於上市公司股東的扣除非經常性損益的淨利潤-241.39萬元;基本每股收益0.1093元。
報吿期內,公司實現銷售收入較上年同期增加47.28%;主要系報吿期內,公司不斷擴大產品矩陣,緊抓市場機遇,加大產品銷售力度,提升客户份額,部分新產品已經開始向國內外頭部客户出貨,同比去年同期公司的上半年銷售收入大幅增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.